Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02857426
Title A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL) (CheckMate 647)
Acronym CheckMate 647
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Bristol-Myers Squibb
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | HUN | FRA | DEU | CZE | CAN | BRA

Facility Status City State Zip Country Details
University of Alabama at Birmingham Birmingham Alabama 35294-3410 United States Details
City Of Hope Medical Center Duarte California 91010 United States Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
H. Lee Moffitt Cancer Center & Research Inst, Inc Tampa Florida 33612 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Massachusetts General Hospital Boston Massachusetts 02215 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Mayo Clinic Rochester Rochester Minnesota 55905 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Columbia University New York New York 10032 United States Details
Fox Chase Cancer Center Philadelphia Pennsylvania 19111 United States Details
Baylor Research Institute Dallas Texas 75246 United States Details
Swedish Medical Center Seattle Washington 98122 United States Details
Instituto Do Cancer Mae De Deus / Cor Hospital Mae De Deus Porto Alegre Rio Grande Do Sul 90470-340 Brazil Details
Fundacao Pio Xii Hosp Cancer De Barretos Barretos Sao Paulo 14784-400 Brazil Details
Hospital Das Clinicas - Fmusp Sao Paulo 05403-000 Brazil Details
BC Cancer Agency - Vancouver Centre Vancouver British Columbia V5Z 4E6 Canada Details
Princess Margaret Cancer Centre Toronto Ontario M5G 2M9 Canada Details
CHU de Quebec Quebec G1J 1Z4 Canada Details
I. interni klinika - klinika hematologie 1. LF UK a VFN v Praze Praha 2 128 08 Czechia Details
Local Institution Bordeaux 33076 France Details
Local Institution Caen 14000 France Details
Local Institution La Tronche 3870 France Details
Local Institution Lille Cedex 59037 France Details
Local Institution Paris cedex 13 75651 France Details
Centre Hospitalier Lyon Sud - UPCO Pierre Benite 69495 France Details
Local Institution Rennes Cedex 9 35033 France Details
Local Institution St. Cloud 92210 France Details
Local Institution Tours Cedex 9 37044 France Details
Klinikum Stuttgart Stuttgart 70174 Germany Details
Local Institution Hong Kong Hong Kong Details
Local Institution Budapest 1083 Hungary Details
Belgyogyaszati Onkologia OOI Budapest 1122 Hungary Details
Local Institution Debrecen 4032 Hungary Details
Local Institution Haifa 3109601 Israel Details
Local Institution Jerusalem 91120 Israel Details
Local Institution Petah Tikva 4941492 Israel Details
Local Institution Tel Aviv 64239 Israel Details
Irccs Ospedale S. Raffaele Milano 20132 Italy Details
Fondazione Policlinico Universitario A. Gemelli Roma 00168 Italy Details
Istituto Clinico Humanitas Rozzano (milano) 20089 Italy Details
Local Institution Nagoya Aichi 4648681 Japan Details
Local Institution Fukuoka-shi Fukuoka 811-1395 Japan Details
Local Institution Hidaka-shi Saitama 3501298 Japan Details
Local Institution Chuo-ku Tokyo 1040045 Japan Details
Local Institution Kotoku Tokyo 1358550 Japan Details
Local Institution Mitaka-shi Tokyo 181-8611 Japan Details
Local Institution Yamagata 9909585 Japan Details
Local Institution Moscow 121309 Russian Federation Details
Local Institution Singapore 169610 Singapore Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field